Literature DB >> 17643826

Ecto-5'-nucleotidase/CD73 inhibition by quercetin in the human U138MG glioma cell line.

Elizandra Braganhol1, Alessandra S K Tamajusuku, Andressa Bernardi, Márcia R Wink, Ana M O Battastini.   

Abstract

Gliomas are the most malignant of the primary brain tumors. Nucleotides represent an important class of extracellular molecules that are crucial for the normal function of the nervous system. ATP and adenosine can stimulate cell proliferation in different glioma cell lines; the events induced by extracellular adenine nucleotides are controlled by the action of ecto-nucleotidases, which hydrolyze ATP into adenosine in the extracellular space. Recent studies have shown that quercetin has an anti-proliferative effect on the U138MG glioma cell line. Since evidence suggests that purinergic signaling is involved in the growth and progression of glioma and, taking into consideration the anti-proliferative effect elicited by quercetin in this tumor type, the aim of the present study was to better investigate the extracellular metabolism of AMP and evaluate the effect of quercetin on this system in the human U138MG glioma cell line. The adenine products secreted by glioma cells were first characterized; extracellular AMP was efficiently metabolized by the glioma culture, demonstrating a very active ecto-5'-NT/CD73. Quercetin was able to inhibit the ecto-5'-NT/CD73 activity and modulate its expression. In addition, the cell treatment with APCP (alpha,beta-methyleneadenosine-5'-diphosphate), an ecto-5'-NT/CD73 inhibitor, led to a significant reduction in glioma cell proliferation. We suggest that the inhibition of ecto-5'-NT/CD73 may result in a decrease in extracellular adenosine production with a consequent reduction in tumor progression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17643826     DOI: 10.1016/j.bbagen.2007.06.003

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  21 in total

1.  Hypothyroidism Enhanced Ectonucleotidases and Acetylcholinesterase Activities in Rat Synaptosomes can be Prevented by the Naturally Occurring Polyphenol Quercetin.

Authors:  Jucimara Baldissarelli; Adriana Santi; Roberta Schmatz; Fátima Husein Abdalla; Andréia Machado Cardoso; Caroline Curry Martins; Glaecir R Mundstock Dias; Nicéia Spanholi Calgaroto; Luana Paula Pelinson; Karine Paula Reichert; Vania Lucia Loro; Vera Maria Melchiors Morsch; Maria Rosa Chitolina Schetinger
Journal:  Cell Mol Neurobiol       Date:  2016-02-16       Impact factor: 5.046

2.  Protective effect of quercetin in ecto-enzymes, cholinesterases, and myeloperoxidase activities in the lymphocytes of rats exposed to cadmium.

Authors:  Fátima Husein Abdalla; Andréia Machado Cardoso; Roberta Schmatz; Jamile Fabbrin Gonçalves; Jucimara Baldissarelli; Caroline Curry Martins; Daniela Zanini; Lizielle Souza de Oliveira; Pauline da Costa; Victor Camera Pimentel; Luciane Belmonte Pereira; Cibele Lima Lhamas; Maria Rosa Chitolina Schetinger; Vera Maria Morsch; Cinthia Melazzo Andrade Mazzanti
Journal:  Mol Cell Biochem       Date:  2014-07-27       Impact factor: 3.396

3.  Structure-Activity Relationship of Purine and Pyrimidine Nucleotides as Ecto-5'-Nucleotidase (CD73) Inhibitors.

Authors:  Anna Junker; Christian Renn; Clemens Dobelmann; Vigneshwaran Namasivayam; Shanu Jain; Karolina Losenkova; Heikki Irjala; Sierra Duca; Ramachandran Balasubramanian; Saibal Chakraborty; Frederik Börgel; Herbert Zimmermann; Gennady G Yegutkin; Christa E Müller; Kenneth A Jacobson
Journal:  J Med Chem       Date:  2019-03-21       Impact factor: 7.446

4.  Anti-CD73 in cancer immunotherapy: awakening new opportunities.

Authors:  Luca Antonioli; Gennady G Yegutkin; Pál Pacher; Corrado Blandizzi; György Haskó
Journal:  Trends Cancer       Date:  2016-02-01

Review 5.  Purinergic signalling and cancer.

Authors:  Geoffrey Burnstock; Francesco Di Virgilio
Journal:  Purinergic Signal       Date:  2013-12       Impact factor: 3.765

6.  NTPDase3 and ecto-5'-nucleotidase/CD73 are differentially expressed during mouse bladder cancer progression.

Authors:  Liliana Rockenbach; Elizandra Braganhol; Fabrícia Dietrich; Fabrício Figueiró; Manoella Pugliese; Maria Isabel Albano Edelweiss; Fernanda Bueno Morrone; Jean Sévigny; Ana Maria Oliveira Battastini
Journal:  Purinergic Signal       Date:  2014-01-26       Impact factor: 3.765

7.  The role of ecto-5'-nucleotidase/CD73 in glioma cell line proliferation.

Authors:  Luci Bavaresco; Andressa Bernardi; Elizandra Braganhol; Angélica Regina Cappellari; Liliana Rockenbach; Patrícia Fernandes Farias; Márcia Rosângela Wink; Andrés Delgado-Cañedo; Ana Maria Oliveira Battastini
Journal:  Mol Cell Biochem       Date:  2008-07-18       Impact factor: 3.396

Review 8.  Immunity, inflammation and cancer: a leading role for adenosine.

Authors:  Luca Antonioli; Corrado Blandizzi; Pál Pacher; György Haskó
Journal:  Nat Rev Cancer       Date:  2013-11-14       Impact factor: 60.716

9.  CD73: an emerging checkpoint for cancer immunotherapy.

Authors:  Siqi Chen; Derek A Wainwright; Jennifer D Wu; Yong Wan; Daniela E Matei; Yi Zhang; Bin Zhang
Journal:  Immunotherapy       Date:  2019-06-21       Impact factor: 4.196

Review 10.  Drug repurposing for targeting cyclic nucleotide transporters in acute leukemias - A missed opportunity.

Authors:  Dominique R Perez; Larry A Sklar; Alexandre Chigaev; Ksenia Matlawska-Wasowska
Journal:  Semin Cancer Biol       Date:  2020-02-07       Impact factor: 15.707

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.